KTTA stock news

KTTA stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

3 wire items

2026-09-16 20:13:01 UTC#323411newconfirmednews

Pasithea Therapeutics to delist KTTAW warrants on Sept 17, 2026; common stock KTTA remains unaffected

tradingviewimportance 0.40trust 0.80Pasithea Therapeutics Corp. -0.30Nasdaq, Inc. -0.20

2026-08-21 21:13:01 UTC#207638newconfirmednews

Pasithea Therapeutics granted 180-day Nasdaq extension until Feb 16, 2027 to regain $1.00 bid price compliance

tradingviewimportance 0.40trust 0.90Pasithea Therapeutics Corp. -0.40Nasdaq, Inc. -0.20

2026-08-10 11:46:08 UTC#152302newforecastnews

Pasithea Therapeutics (KTTA) Q2 2026 Earnings Preview: Expected EPS Loss of $0.16

reutersimportance 0.30trust 0.80Pasithea Therapeutics Corp. -0.10London Stock Exchange Group plc 0